Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease
- PMID: 3492164
- DOI: 10.7326/0003-4819-106-2-196
Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease
Abstract
The effects of broad-spectrum antibiotic and placebo therapy in patients with chronic obstructive pulmonary disease in exacerbation were compared in a randomized, double-blinded, crossover trial. Exacerbations were defined in terms of increased dyspnea, sputum production, and sputum purulence. Exacerbations were followed at 3-day intervals by home visits, and those that resolved in 21 days were designated treatment successes. Treatment failures included exacerbations in which symptoms did not resolve but no intervention was necessary, and those in which the patient's condition deteriorated so that intervention was necessary. Over 3.5 years in 173 patients, 362 exacerbations were treated, 180 with placebo and 182 with antibiotic. The success rate with placebo was 55% and with antibiotic 68%. The rate of failure with deterioration was 19% with placebo and 10% with antibiotic. There was a significant benefit associated with antibiotic. Peak flow recovered more rapidly with antibiotic treatment than with placebo. Side effects were uncommon and did not differ between antibiotic and placebo.
Similar articles
-
Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice.Thorax. 1995 Jul;50(7):758-63. doi: 10.1136/thx.50.7.758. Thorax. 1995. PMID: 7570411 Free PMC article. Clinical Trial.
-
Acute exacerbation of COPD: factors associated with poor treatment outcome.Chest. 2000 Mar;117(3):662-71. doi: 10.1378/chest.117.3.662. Chest. 2000. PMID: 10712989
-
Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2010 Jan 15;181(2):150-7. doi: 10.1164/rccm.200906-0837OC. Epub 2009 Oct 29. Am J Respir Crit Care Med. 2010. PMID: 19875685 Clinical Trial.
-
Role of antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease.Ann Pharmacother. 2001 May;35(5):576-81. doi: 10.1345/aph.19411. Ann Pharmacother. 2001. PMID: 11346065 Review.
-
Antibiotics for exacerbations of chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2006 Apr 19;(2):CD004403. doi: 10.1002/14651858.CD004403.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2011 Jan 19;(1):CD004403. doi: 10.1002/14651858.CD004403.pub3. PMID: 16625602 Updated. Review.
Cited by
-
Clinical features and 1-year outcomes of variable obstruction in participants with preserved spirometry: results from the ECOPD study in China.BMJ Open Respir Res. 2024 May 24;11(1):e002210. doi: 10.1136/bmjresp-2023-002210. BMJ Open Respir Res. 2024. PMID: 38789282 Free PMC article.
-
[Rational use of antibiotics treatment in acute bronchitis].Med Mal Infect. 1992 Feb;22:149-152. doi: 10.1016/S0399-077X(05)81464-7. Epub 2005 Jun 20. Med Mal Infect. 1992. PMID: 38620288 Free PMC article. French.
-
The Exacerbation, Not the Patient, Determines Chronic Obstructive Pulmonary Disease Exacerbation Care Seeking.Ann Am Thorac Soc. 2024 Apr;21(4):541-542. doi: 10.1513/AnnalsATS.202401-010ED. Ann Am Thorac Soc. 2024. PMID: 38557421 Free PMC article. No abstract available.
-
Clinical characterization and outcomes of impulse oscillometry-defined bronchodilator response: an ECOPD cohort-based study.Respir Res. 2024 Mar 30;25(1):149. doi: 10.1186/s12931-024-02765-7. Respir Res. 2024. PMID: 38555433 Free PMC article.
-
Implementation of the Care Bundle for the Management of Chronic Obstructive Pulmonary Disease with/without Heart Failure.J Clin Med. 2024 Mar 12;13(6):1621. doi: 10.3390/jcm13061621. J Clin Med. 2024. PMID: 38541845 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical